- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Amicus Therapeutics Inc
+ Add to WatchlistAM6:GR
2.619 EUR 0.047 1.83%As of 02:16:43 ET on 05/20/2013.
Snapshot for Amicus Therapeutics Inc (AM6)
| Open: | 2.620 | Day's Range: | 2.619 - 2.629 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 2.572 | 52wk Range: | 1.922 - 5.246 | 1-Yr Rtn: | -27.31% |
Key Statistics for AM6
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -1.4140 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 113 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AM6
Company Profile & Key Executives for AM6
Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.
| John F CrowleyChairman/CEO | William D Baird III "Chip"Chief Financial Officer |
| David J LockhartChief Scientific Officer | Bradley L CampbellChief Business Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AM6 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page